Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy

NCT01079325 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

170

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2
Diabetic Polyneuropathy

Interventions

DRUG: SB-509
OTHER: Saline

Sponsor

Sangamo Therapeutics

Collaborators

[object Object]